Search BioPortfolio:
BioPortfolio
Web
Home
Careers
Conferences
Directory
Drug Discovery
Genes
InDepth
Marketing
News
Reports
Videos
Search
Contact
Leishmaniasis News and Headlines
Leishmaniasis News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's
Leishmaniasis
news alerts
.
Site Map
>
Biotechnology News
>
Health News
> Leishmaniasis
.
Spread of Vector-Borne Diseases and Neglect of Leishmaniasis, Europe
Center for Disease Control and Prevention:
similar ...
iCo Therapeutics Reports New iCo-009 (Oral Amphotericin B) Preclinical Results
Pharma Live:
similar ...
Novel approach to drug insolubility strengthens PolyTherics patent estate
News-Medical.Net:
similar ...
Novel Approach to Drug Insolubility Strengthens PolyTherics Patent Estate
Pharma Live:
similar ...
Polytherics Complex technology to make drug solubility simple
In-Pharmatechnologist:
similar ...
Novel Approach To Drug Insolubility Strengthens PolyTherics Patent Estate
Medical News Today:
similar ...
iCo Therapeutics acquires worldwide rights to oral Amphotericin B
PharmaBiz:
similar ...
Infectious Disease Research Institute and Chembio to Develop Tests for Leishmaniasis and Leprosy
TB & Outbreaks Week via NewsRx.com:
similar ...
Infectious Disease Research Institute and Chembio to Develop Tests for Leishmaniasis and Leprosy
TB & Outbreaks Week via NewsRx.com:
similar ...
Infectious Disease Research Institute and Chembio to Develop Tests for Leishmaniasis and Leprosy
PR Newswire:
similar ...
Chembio and Infectious Disease Research Institute Collaborating on Development of Rapid Tests for Leishmaniasis and Leprosy
Market Wire, Incorporated:
similar ...
OneWorld Health's First Approved Drug Added to WHO Essential Medicines List
Business Wire:
similar ...
Study data from University Nacional Autonoma of Mexico update knowledge of leishmaniasis
TB & Outbreaks Week via NewsRx.com:
similar ...
New leishmaniasis immunology research from Ege University, Department of Parasitology outlined
TB & Outbreaks Week via NewsRx.com:
similar ...
New leishmaniasis vaccines research from Addenbrooke's Hospital described
Virus Weekly via NewsRx.com:
similar ...
U.S. FDA grants VioQuest, U.S. Army orphan drug status for cutaneous leishmaniasis therapy
Medical Letter on the CDC & FDA via NewsRx.com:
similar ...
VioQuest, with U.S. Army, granted orphan drug status for VQD-001 for cutaneous leishmaniasis
Medical Letter on the CDC & FDA via NewsRx.com:
similar ...
Amphotericin IND
Business Wire:
similar ...
VioQuest Pharmaceuticals, In Partnership with U.S. Army, Granted Orphan Drug Designation for VQD-001 (Sodium Stibogluconate) for Cutaneous Leishmaniasis
PR Newswire:
similar ...
New HIV/AIDS immunology study results reported from University Hospital
Virus Weekly via NewsRx.com:
similar ...
